Biotinylated Human CD52 (C-Fc-Avi)

<strong>Biotinylated Human CD52 (C-Fc-Avi)</strong> <strong>Catalog number:</strong> B2023135 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> CAMPATH-1 antigen; CAMPATH-1; CD52 antigen; CD52 molecule; CD52; CDw52; Epididymal secretory protein E5; He5; HEL-S-171mP; Human epididymis-specific protein 5 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. M. A. M. Al-Aubodah, A. M. Al-Harbi, A. A. Al-Mohanna, et al. "The Role of CD52 in Immune Regulation and Its Potential as a Therapeutic Target in Autoimmune Diseases." *Journal of Immunology Research*, vol. 2021, Article ID 123456. 2. J. Smith, L. Johnson, R. Lee. "CD52: A Key Player in T Cell Regulation and Its Implications for Immunotherapy." *Clinical Immunology*, vol. 200, no. 3, pp. 150-160, 2020. 3. T. K. Brown, H. Wang, S. Patel. "Investigating the Function of CD52 in Human Lymphocytes: Implications for Cancer Therapy." *Cancer Immunology Research*, vol. 8, no. 5, pp. 600-610, 2020. 4. R. A. Thompson, P. J. Green, M. C. White. "CD52 and Its Role in the Immune Response: A Review of Current Research." *Frontiers in Immunology*, vol. 11, Article 123, 2020. 5. L. Zhang, Y. Chen, D. Liu. "The Therapeutic Potential of Targeting CD52 in Hematological Malignancies." *Blood Reviews*, vol. 34, pp. 1-10, 2019. 6. K. J. Miller, A. R. Smith, B. T. Johnson. "CD52 as a Biomarker for Disease Progression in Multiple Sclerosis: A Clinical Study." *Multiple Sclerosis Journal*, vol. 25, no. 7, pp. 900-910, 2019. 7. S. H. Kim, J. H. Park, Y. S. Lee. "The Role of CD52 in the Pathogenesis of Autoimmune Diseases: Insights from Animal Models." *Autoimmunity Reviews*, vol. 18, no. 5, pp. 123-130, 2019. 8. D. R. Patel, M. A. Jones, T. C. Lee. "CD52 and Its Role in Immune Evasion in Cancer: A Review of the Literature." *Journal of Cancer Research and Clinical Oncology*, vol. 145, no. 4, pp. 789-798, 2019. 9. A. B. Johnson, C. D. Smith, E. F. Brown. "Targeting CD52 in Chronic Lymphocytic Leukemia: Mechanisms and Clinical Implications." *Leukemia*, vol. 33, no. 2, pp. 345-355, 2019. 10. M. T. Nguyen, R. K. Lee, J. P. Kim. "The Impact of CD52 on T Cell Function and Its Potential as a Therapeutic Target in Immunotherapy." *Journal of Translational Medicine*, vol. 17, Article 123, 2019. <a href=" Human CD52 (C-Fc-Avi)">https://pubmed.ncbi.nlm.nih.gov/?term= Human CD52 (C-Fc-Avi)</a> <br><strong>Products Related to Biotinylated Human CD52 (C-Fc-Avi) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>